Mayne Pharma Group Limited
Mayne Pharma Group Limited (MAYNF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MAYNF · as of Jun 9, 2026
Key Statistics
Explore Mayne Pharma Group Limited Data
maynf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
maynf competitorsMAYNF
AONC
BHCCF
BHHKF
CPHRF
EVGRFStock Performance
Full HistoryAbout Mayne Pharma Group Limited
Mayne Pharma Group Limited is an Australian-headquartered specialty pharmaceutical enterprise, engaged in the development, production, and marketing of both patented (branded) and generic drug formula…
what is mayne pharma group limited · maynf stock overview · mayne pharma group limited company profile · who is mayne pharma group limited ceo · maynf OTC · mayne pharma group limited headquarters · mayne pharma group limited business segments
About Stock Overview & Key Data
Mayne Pharma Group Limited (MAYNF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Mar 22, 2013. As of the latest trading session, MAYNF stock price is $1.55, with a market capitalization of $125.9M. The stock has returned -54.41% over the past 12 months and -25.12% year-to-date.
In fiscal year 2025, Mayne Pharma Group Limited reported revenue of $408.1M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Mayne Pharma Group Limited (MAYNF) stock price is $1.55. The stock is traded on OTC under the ticker symbol MAYNF. The 52-week range is $1.40 – $4.00.